Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5427]
News [12613]
Articles [172]
Editorials [5]
Conferences [246]
elearning [17]
Indoximod combined with chemotherapy in newly diagnosed AML patients
Dr Ashkan Emadi - University of Maryland Medical Centre, Maryland, USA
Indoximod combined with chemotherapy in newly diagnosed AML patients ( Dr Ashkan Emadi - University of Maryland Medical Centre, Maryland, USA )
17 Dec 2018
Combined ibrutinib and venetoclax in patients with treatment-naïve high-risk CLL
Dr Nitin Jain - MD Anderson Cancer Centre, Houston, USA
Combined ibrutinib and venetoclax in patients with treatment-naïve high-risk CLL ( Dr Nitin Jain - MD Anderson Cancer Centre, Houston, USA )
17 Dec 2018
Phase II trial of nivolumab combined with ibrutinib for patients with Richter...
Dr Nitin Jain - MD Anderson Cancer Centre, Houston, USA
Phase II trial of nivolumab combined with ibrutinib for patients with Richter transformation ( Dr Nitin Jain - MD Anderson Cancer Centre, Houston, USA )
17 Dec 2018
Ibrutinib with obinutuzumab in patients with chronic lymphocytic leukaemia
Dr Carolina Moreno Atanasio - Hospital de la Santa Creu i Sant Pau, Barcelona...
Ibrutinib with obinutuzumab in patients with chronic lymphocytic leukaemia ( Dr Carolina Moreno Atanasio - Hospital de la Santa Creu i Sant Pau, Barcelona, Spain )
17 Dec 2018
Results of using dara-CyBorD to treat patients with newly diagnosed or relapsed...
Dr Habte Yimer - Texas Oncology, Tyler, USA
Results of using dara-CyBorD to treat patients with newly diagnosed or relapsed multiple myeloma ( Dr Habte Yimer - Texas Oncology, Tyler, USA )
17 Dec 2018
Regional radiation benefits high risk breast cancer patients
Prof David Dodwell - Nuffield Department of Population Health, Oxford, UK
Regional radiation benefits high risk breast cancer patients ( Prof David Dodwell - Nuffield Department of Population Health, Oxford, UK )
14 Dec 2018
Axillary dissection in clinically node negative breast cancer patients...
Dr Andrea Barrio - Memorial Sloan Kettering Cancer Centre, New York, USA
Axillary dissection in clinically node negative breast cancer patients undergoing breast conserving surgery ( Dr Andrea Barrio - Memorial Sloan Kettering Cancer Centre, New York, USA )
14 Dec 2018
Practical approach to the management of the axilla after neoadjuvant...
Dr Andrea Barrio - Memorial Sloan Kettering Cancer Centre, New York, USA
Practical approach to the management of the axilla after neoadjuvant chemotherapy ( Dr Andrea Barrio - Memorial Sloan Kettering Cancer Centre, New York, USA )
14 Dec 2018
Alpelisib plus fulvestrant for advanced breast cancer: Subgroup analyses from...
Dr Dejan Juric - Massachusetts General Hospital, Boston, USA
Alpelisib plus fulvestrant for advanced breast cancer: Subgroup analyses from the phase III SOLAR-1 trial ( Dr Dejan Juric - Massachusetts General Hospital, Boston, USA )
14 Dec 2018
Polygenic risk scores for breast cancer: ready or not?
Prof Gareth Evans - University of Manchester, Manchester, UK
Polygenic risk scores for breast cancer: ready or not? ( Prof Gareth Evans - University of Manchester, Manchester, UK )
14 Dec 2018
Modulation of anti-tumour immunity using CDK4/6 inhibitors
Dr Shom Goel - Dana-Farber Cancer Institute, Boston, USA
Modulation of anti-tumour immunity using CDK4/6 inhibitors ( Dr Shom Goel - Dana-Farber Cancer Institute, Boston, USA )
14 Dec 2018
Brain metastases developed from HER2 positive and triple negative breast cancer
Dr Patricia Steeg - National Cancer Institute, Bethesda, USA
Brain metastases developed from HER2 positive and triple negative breast cancer ( Dr Patricia Steeg - National Cancer Institute, Bethesda, USA )
14 Dec 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation